1. Sutherland EW, Rall TW: Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles. JBC 232: 1077?1091, 1958
2. Waldman SA, Murad F: Cyclic GMP synthesis and function. Pharmacological Reviews 39: 163?196, 1987
3. Reeves ML, England PJ: Cardiac phosphodiesterases and the functional effects of selective inhibition. In: JA Beavo, MD Housley (eds) Cyclic nucleotide phosphodiesterases: structure, regulation and drug action. John Wiley & Sons, Ltd., Chichester, 1990, pp 299?316
4. Sonnenburg WK, Beavo JA: Cyclic GMP and regulation of cyclic nucleotide hydrolysis. In: F Murad (ed.) Cyclic GMP: synthesis, metabolism, and function. Academic Press, San Diego, 1992, in press
5. Harrison SA, Reifsnyder DH, Gallis B, Cadd GC, Beavo JA: Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs. Mol Phcol 29: 506?514, 1986